Cite
HARVARD Citation
Sternberg, C. et al. (n.d.). 930TiPPhase II/III study of rogaratinib versus chemotherapy in patients with locally advanced or metastatic urothelial carcinoma selected based on FGFR1/3 mRNA expression. Annals of oncology. p. . [Online].